INTRODUCTION {#S1}
============

We remember our lives as sequences of events, which is at the core of episodic memory. The temporal organization of memory is thought to be useful for disambiguating memories with overlapping content and is studied using a wide array of tasks ([@R18]; [@R40]; [@R86]; [@R2]; [@R3]; [@R26]).

Neurobiologically, memory for sequences of events relies on the hippocampus (HC) ([@R32]; [@R51]; [@R7]) and medial prefrontal cortex (mPFC) ([@R10]; [@R28]; [@R36]; [@R11]; [@R84]). Each region serves a different role in sequence memory ([@R45]). The HC is thought to associate information with a spatiotemporal context ([@R25]; [@R55]; [@R54]; [@R78]), whereas mPFC is thought to influence the retrieval of information relevant to an action or decision ([@R31]; [@R29]; [@R71]).

In rats, mPFC is ideally situated to influence memory retrieval through its projections to the thalamus and cortex ([@R76]; [@R17]; [@R89]; [@R42]). mPFC may bias different sequence retrieval strategies through its top-down projection pathways. If this is the case, selective inhibition of distinct mPFC projection pathways should impair sequence memory with different effects.

The most significant mPFC projections target the nucleus reuniens of the thalamus (RE) and the perirhinal cortex (PER) because these regions are interconnected with HC ([@R27]). The RE receives widely distributed projections from limbic sites ([@R89], [@R90]; [@R63]), but RE projections primarily innervate HC, parahippocampus, and prefrontal cortex ([@R91]; [@R92]). Given the absence of direct projections from mPFC to HC, RE represents the primary route as follows: HC→mPFC→RE→HC ([@R93]). Notably, RE is critical to a variety of working memory tasks that have been linked to mPFC deficits ([@R20]; [@R24]; [@R14]; [@R37]; [@R96]; [@R35]; [@R48]; [@R95]).

Like RE, PER is the nexus of bidirectional communication between HC and mPFC ([@R33]). PER is critical to memory for complex stimuli ([@R66]; [@R12]; [@R1]; [@R9]; [@R30]), as well as for temporal aspects of memory ([@R65]; [@R13]; [@R4]; [@R10]; [@R8]; [@R16]; [@R68]).

Here, we identify the mPFC→RE and mPFC→PER projection pathways, and then test their contributions to sequence memory using a task that allows for an analysis of the underlying strategy ([@R5], [@R7]). Briefly, rats sampled two sequences of odors and demonstrated sequence memory by identifying "in sequence" (InSeq) and "out of sequence" (OutSeq) odors. First we, examined mPFC projections to RE and PER using anterograde and retrograde tracers. Second, we tested the role of mPFC in sequence memory in rats expressing inhibitory DREADDs (designer receptor exclusively activated by designer drugs; hM4Di). Third, we tested the role of mPFC→RE and mPFC→PER pathways using a synaptic-silencing approach ([@R60]; [@R81]; [@R75]; [@R79]; [@R58]). Finally, we used a lag analysis across specific probes (e.g., AB[A]{.ul}, where A is a repeated item from two positions earlier, or AB[D]{.ul}, where D skips ahead one position) to look at the unique contributions of mPFC→RE and mPFC→PER pathways. Theoretically, differences in lag performance patterns on repeated items can be used to distinguish the contributions of working memory and temporal context memory.

We found that distinct populations of mPFC cells project to RE and PER. We then show mPFC is critical to sequence memory. Silencing mPFC→RE and mPFC→PER projections abolished sequence memory and led to a unique pattern of behavioral deficits. Silencing mPFC→RE produced a deficit consistent with reduced working memory, whereas silencing mPFC→PER produced a deficit consistent with reduced temporal context memory (i.e., graded memory retrieval based on sequential proximity). These findings advance the concept that separate mPFC circuits target RE and PER and differentially control sequence memory.

RESULTS {#S2}
=======

Incubation Time of AAV-hM4Di (Adeno-Associated Virus) in mPFC Neurons {#S3}
---------------------------------------------------------------------

We targeted mPFC, which has been implicated in the temporal organization of memory ([@R87]; [@R21]; [@R84], [@R85]), using an axon-preferring hM4Di variant (AAV9.CAG.mCherry-2a-hM4D~i~^nrxn^.WPRE.SV40), referred to as hM4D~i~^nrxn^ (neurexin; [@R81]). This variant exhibits enhanced axonal expression and reduced somatic expression. Activation of the hM4D~i~^nrxn^ variant at synaptic terminals inhibits synaptic transmission without somatic hyperpolarization ([@R81]). The gestation time for these experiments was determined by injecting hM4Di in a separate group of rats (n = 4, 1 per time point) that were perfused at 1, 2, 4, or 8 weeks after surgery. At 2 weeks, the virus was well expressed ([Figure S1](#SD1){ref-type="supplementary-material"}).

Localization of AAV-hM4Di Transduction and Expression Patterns {#S4}
--------------------------------------------------------------

We used immunohistochemistry to visualize hM4Di expression resulting from the AAV viral constructs and found expression to be mostly restricted to the anterior cingulate and prelimbic cortices of mPFC. To estimate the localization of hM4Di, we processed slices for dual immunofluorescence in a subset of animals (n = 3) using antisera for mCherry and NeuN ([Figure 1A](#F1){ref-type="fig"}). We counted mCherry-labeled cells and NeuN-labeled cells at three anterior-posterior (AP) levels: at the core of the injection site in layers 5/6 of mPFC (AP +3.2); and anterior/posterior to this level (±120 μm), defining the ratio of mCherry to NeuN-labeled cells as the percentage of hM4Di-infected cells ([Figure 1B](#F1){ref-type="fig"}). Overall, hM4Di-infected neurons in prelimbic cortex (48.99% ± 4.32%) and anterior cingulate cortex (50.61% ± 3.93%) did not differ (t~(16)~ = 0.779, p = 0.447).

Organization of mPFC Projections to RE and PER {#S5}
----------------------------------------------

We examined the organization of mPFC projections to RE and PER using anterograde and retrograde methods. First, we mapped mPFC projections to RE and PER using immunolabeling of mCherry terminals taking advantage of the anterograde properties of AAV9.CAG.mCherry-2a-hM4D~i~^nrxn^. Fiber expression patterns were characteristic of mPFC projection sites to the forebrain, including the orbital and insular cortices, ventral striatum, and the entire intralaminar and midline thalamus, including predominantly RE ([Figure 1C](#F1){ref-type="fig"}), PER ([Figure 1D](#F1){ref-type="fig"}), and entorhinal cortices, indicating good anterograde transport and allowing for clozapine *N*-oxide (CNO) inhibition of mPFC terminal fibers in RE ([@R89]; [@R42], [@R43]; [@R93]) and PER ([@R33]). The density of mPFC fibers across subdivisions of each terminal site was quantified in a subset of rats (n = 3). mPFC fiber densities in RE and PER were tested using one-sample t tests against a relative density (RD) = 1 (the referenced area), which yielded significant differences of p ≤ 0.001 for all regions and laminar divisions of RE and PER.

RE contained a dense plexus of hM4Di fibers that spanned the rostrocaudal extent of the nucleus. mPFC hM4Di fibers distributed strongest to the lateral aspects of RE including perireuniens (periRE) ([Figures 1C](#F1){ref-type="fig"} and [4C](#F4){ref-type="fig"}). ROIs for RE were taken from six separate subdivisions across the AP plane: medial (REm), dorsal (REd), and lateral (REl) divisions rostrally and medial (REcm, dorsal \[REcd\], and periRE laterally in caudal RE). Across anterior RE, there was a significant difference in the distribution of mCherry-labeled fibers (F~(2,16)~ = 8.81, p = 0.003). hM4Di mPFC axons targeted REd (RD = 1.166 ± 0.078) and REl (RD = 1.264 ± 0.103) with the heaviest of fiber innervation in the lateral "wings" ([Figures 1C](#F1){ref-type="fig"} and [4C](#F4){ref-type="fig"}). By comparison, the density of mPFC axons in REm (RD = 1.095 ± 0.480) was substantially less than REl (p = 0.001) and REd (p = 0.054). There was a similar pattern of innervation across RE for the posterior aspect of RE, with significant differences in density across subdivisions mediolaterally (F~(2,12)~ = 4.334, p = 0.038) with intense fiber labeling in periRE (RD = 1.238 ± 0.100), followed by REd (RD = 1.161 ± 0.063), and fewer fibers covering the medial REcp (RD = 1.132 ± 0.051).

In PER, the density of mPFC fibers differed significantly across layers of PER (F~(3,24)~ = 7.025, p = 0.014), signifying a distinct laminar organization in PER. hM4Di mPFC axons terminated densely in layer I, with significant differences (RD = 1.075 ± 0.06) compared to a paucity of fibers in layers II/III (RD = 1.033 ± 0.025; [Figures 1D](#F1){ref-type="fig"} and [5C](#F5){ref-type="fig"}). There were no differences in hM4Di fiber density across layers II/III, V (RD = 1.029 ± 0.017), and VI (RD = 1.035 ± 0.019).

Separate Populations of mPFC Neurons Project to RE and PER {#S6}
----------------------------------------------------------

Next, we tested whether the same cells in mPFC project to both RE and PER, or whether these are separate cell populations. Rats (n = 4) underwent surgery for a dual retrograde fluorescence labeling of cholera toxin subunit B green (CTB-488) and red (CTB-594) in RE and PER. We analyzed cells in the anterior cingulate cortex, prelimbic cortex, and infralimbic cortex across layers for retrograde labeling from either RE and PER. mPFC→RE projecting cells were found in layers II/III, V, and VI ([Figures 1E](#F1){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}). These projections were found throughout dorsal and ventral prelimbic cortex, and infralimbic cortex, predominantly in layers V ([Figure 1](#F1){ref-type="fig"}Fi; dPL, t~(3)~ = 7.686, p = 0.005; vPL, t~(3)~ = 4.909, p = 0.016; IL, t~(3)~ = 5.603, p = 0.011) and VI (dPL, t~(3)~ = 5.508, p = 0.012; vPL, t~(3)~ = 6.210, p = 0.008; IL, t~(3)~ = 21.840, p = 2.100 × 10^−4^). Only a few cells were found in anterior cingulate cortex. mPFC→PER projecting cells were observed throughout layers II/III and V, with the highest density in layer II/III ([Figure 1](#F1){ref-type="fig"}Fii; dPL, t~(3)~ = 3.654, p = 0.035; IL, t~(3)~ = 3.849, p = 0.031), consistent with previous literature ([@R47]; [@R62]). We did not find labeled cells in layer I. Moreover, we did not find cells in mPFC that projected to both RE and PER (no dual-labeled cells), suggesting no overlap. To identify mPFC projection cell types, a set of tissue was processed using the antibody for glutamic acid decarboxylase (GAD67). We did not find any dual-labeled cells in mPFC for GAD67 and CTB-488/594. This confirmed both populations of mPFC cells are excitatory. Notably, RE is populated exclusively by excitatory glutamatergic cells and presumably mPFC cells synapse onto these neurons ([@R93]). In PER, mPFC axons synapse onto pyramidal cells ([@R47]). Overall, these results show that separate populations of excitatory mPFC neurons, originating from prelimbic and infralimbic cortex, project to RE and PER ([Figure 1G](#F1){ref-type="fig"}).

Sequence Memory Task and Overall Performance {#S7}
--------------------------------------------

We trained rats in an odor sequence task ([@R7]). The behavioral setup was automated and allows for repeated delivery of distinct odors (pure chemical odorants) between two odor ports. We used two sequences, each with four odors that could be delivered at opposite ends of a straight alley ([Figure 2A](#F2){ref-type="fig"}). The use of two sequences eliminated the possibility rats could remember a single sequence throughout the testing period and increased the overall memory load. Furthermore, the use of two sequences allowed us to tease apart different retrieval strategies as rats had to repeatedly retrieve sequences from long-term memory stores. To obtain a water reward, rats had to demonstrate sequence memory by indicating whether the odors were InSeq (holding the nose-poke response \>1 s) or OutSeq (withdrawing from the nose port \<1 s) within a sequence ([Figures 2B](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}). We calculated a sequence memory index (SMI) to measure overall sequence memory while controlling for individual differences in poke-hold behavior ([@R5]). The SMI normalizes the proportion of InSeq and OutSeq items presented during a single session for comparison across sessions and scores sequence memory with a value ranging from −1 to 1. A score of 0 indicates chance performance. A score of 1 indicates perfect performance. Rats were trained in the sequence memory task in progressive stages over several weeks as depicted in [Figure 2D](#F2){ref-type="fig"}. After reaching behavioral criterion (asymptotic sequence memory performance levels over multiple sessions), the rats underwent surgery for bilateral microinjection into mPFC of one of two viral groups (hM4Di^+^: AAV9.CAG.mCherry-2a-hM4Dinrxn.WPRE.SV40; or mCherry-only: AAV9.CB7.CI.mCherry.WPRE.rBG). Chronic guide cannulas were implanted targeting RE and PER bilaterally. After recovery, the rats continued performing the sequence task daily and the experimental manipulations (intraperitoneal \[i.p.\] injections and intracerebral infusions) were started \~3 weeks later.

Overall, the rats demonstrated strong sequence memory ([Figure 2E](#F2){ref-type="fig"}; SMI~well-trained~: 0.302 ± 0.034) and performance did not differ significantly between no-injection/no-intracerebral infusion (No-Inj) and vehicle injection/vehicle infusion (Veh) days ([Figure 2F](#F2){ref-type="fig"}; t~(90)~ = 0.426, p = 0.671). Expected versus observed frequencies were analyzed with G tests to determine whether the observed frequency of InSeq and OutSeq responses for a given session significantly differed from chance. Single-subject analyses revealed every rat differentiated InSeq and OutSeq items at levels well above chance ([Figure S3](#SD1){ref-type="supplementary-material"}; all G tests had p values \< 0.05). Moreover, the rats performed well on position 2 (SMI~Pos2~: 0.282 ± 0.008), position 3 (SMI~Pos3~: 0.321 ± 0.009), and position 4 (SMI~Pos4~: 0.282 ± 0.018), indicating memory for the entire length of each sequence. Position 1 was excluded because an OutSeq item was never presented in that position. Rats also performed well above chance levels on sequence 1 (SMI~Seq1~: 0.305 ± 0.007) and sequence 2 (SMI~Seq2~: 0.292 ± 0.008), with no significant difference between sequences (t~(704)~ = 1.279, p = 0.201), indicating rats successfully switched between the two sequences. Additionally, performance on either of the sequences did not differ significantly on No-Inj and Veh days ([Figure S4A](#SD1){ref-type="supplementary-material"}; sequence 1: t~(52)~ = −1.237, p = 0.222; sequence 2: t~(52)~ = 0.082, p = 0.935).

Suppressing mPFC Activity Impairs Sequence Memory {#S8}
-------------------------------------------------

Evidence suggests the mPFC makes essential contributions to sequence memory ([@R21]). Here, we examined the contribution of mPFC to sequence memory via systemic CNO (i.p., 1 mg/kg) or Veh injections ([Figure 3A](#F3){ref-type="fig"}). The spread of hM4Di^+^ neurons across mPFC was precisely mapped. hM4Di^+^ cells were concentrated in the rostral- to mid-levels of the prelimbic and the anterior cingulate cortex, with dense labeling in the deep cortical layers ([Figure 3B](#F3){ref-type="fig"}). While mCherry-only cells were present throughout the rostral caudal extent of the prelimbic cortex, hM4Di^+^ expression was limited to the rostral aspects of the anterior cingulate cortex, with only a small number of infected cells in the posterior and ventral divisions of the anterior cingulate cortex. In some hM4Di^+^ cases, very small numbers of labeled cells extended into the medial orbital, ventral orbital, infralimbic, medial agranular cortex, and claustrum. The spread of mCherry cells was mapped in the mCherry-only control rats ([Figure S5A](#SD1){ref-type="supplementary-material"}).

We considered each corresponding Veh and CNO injection as a repeated condition across behavioral sessions. Suppression of mPFC neurons with CNO in the hM4Di^+^ group (SMI: 0.056 ± 0.121) significantly reduced SMI scores compared with Veh injection (SMI: 0.254 ± 0.062) the first time we ran this condition ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}; first: t~(12)~ = 5.200, p = 2.210 × 10^−4^, Cohen's d = 1.449), but in the second and third repeats of this condition, we observed no significant effect (second: t~(12)~ = 1.039, p = 0.319; third: t~(4)~ = 0.031, p = 0.977). Overall, we performed three repeated conditions for the first cohort of hM4Di^+^ rats (n = 5). For the second cohort of hM4Di^+^ rats (n = 8) and mCherry-only rats (n = 9), we decreased the number of repeated conditions to two, because the third repeated condition with CNO administration had no effect. We found a significant interaction between the injection and repeated condition (F~(1,12)~ = 5.410, p = 0.038). Furthermore, a linear regression was performed to determine the relationship between CNO administration and repeated conditions. [Figure 3E](#F3){ref-type="fig"} shows there was a moderate positive linear relationship between the repeated conditions and CNO in the hM4Di^+^ group (Pearson's r = 0.490, R^2^ = 0.240, p = 0.003), but no relationship between the repeated condition and Veh in the hM4Di^+^ group (Pearson's r = 0.057, R^2^ = 0.003, p = 0.380). An ANOVA yielded similar results, revealing a significant relationship between repeated conditions and SMI for CNO injections (F~(1,29)~ = 9.167, p = 0.005). Importantly, CNO administration had no significant effects in the mCherry-only group ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}; first: t~(8)~ = 1.208, p = 0.262; second: t~(8)~ = −0.623, p = 0.551), indicating the effects observed in the hM4Di^+^ group were specific to hM4Di receptor activity on mPFC neurons. While infected cells in mCherry-only rats were visualized outside of mPFC, extending to the orbital and motor cortices, the relative density and pattern of labeling of terminal fibers to target sites (RE and PER) was similar to hM4Di^+^ rats. Furthermore, the lack of behavioral effects on these rats confirmed our findings were not associated with non-specific effects related to the viral construct or CNO. mCherry expression in mPFC from a representative case of hM4Di^+^ and mCherry-only is depicted in [Figures S5D](#SD1){ref-type="supplementary-material"} and [S5F](#SD1){ref-type="supplementary-material"}. While neuronal labeling was virtually restricted to the injection sites, sporadic cells (less than \~0.1%−1%) were observed at the target sites, most likely associated with weak retrograde transport of adenovirus constructs ([@R15]; [@R83]) as reported for other hM4Di applications ([@R22]). Finally, sequence memory performance levels were similar between sequence 1 and sequence 2 during systemic CNO and Veh administration, with no significant differences between them ([Figure S4B](#SD1){ref-type="supplementary-material"}; first: Veh, t~(11)~ = −1.023, p = 0.328, CNO, t~(11)~ = −1.231, p = 0.244; second: Veh, t~(9)~ = 2.086, p = 0.067, CNO, t~(10)~ = 0.533, p = 0.606), suggesting a general sequence memory deficit.

Next, we examined the possibility hM4Di suppression of mPFC activity produced non-mnemonic effects relevant to the sequence task. To test for this possibility, we measured the time it took the rats to run between sequences (inter-sequence interval \[ISI\]), the time spent between each odor trial (inter-odor interval \[IOI\]), and nose-poke times. The ISI did not differ significantly between the Veh and CNO conditions in either the hM4Di^+^ or mCherry-only groups ([Figure 3F](#F3){ref-type="fig"}; hM4Di^+^: t~(25)~ = −1.427, p = 0.166; mCherry-only: t~(17)~ = 0.454, p = 0.655), suggesting rats in both groups ran at similar rates between sequences. Furthermore, we found no effects on the IOI ([Figure 3G](#F3){ref-type="fig"}; hM4Di^+^: t~(25)~ = −1.616, p = 0.119; mCherry-only: t~(17)~ = −1.056, p = 0.306), suggesting rats collected water rewards and engaged odors at similar rates. Evaluation of a potential holding bias during the task comparing the Veh and CNO conditions revealed no significant difference between holding (t~(12)~ = −0.875, p = 0.399) and not holding (t~(12)~ = 0.506, p = 0.622). We also evaluated whether CNO affected nose-poke times on InSeq~correct~ and OutSeq~correct~ trials ([Figure 3H](#F3){ref-type="fig"}). In the hM4Di^+^ group, CNO suppression of mPFC activity significantly increased nose-poke times in both InSeq~correct~ and OutSeq~correct~ trials (hM4Di^+^: InSeq~Correct~, t~(25)~ = −2.672, p = 0.013, OutSeq~Correct~, t~(25)~ = −3.944, p = 0.001). No significant differences were detected in the mCherry-only group (mCherry-only: InSeq~Correct~, t~(17)~ = 0.973, p = 0.344, OutSeq~Correct~, t~(17)~ = −0.186, p = 0.853), indicating i.p. CNO did not affect nose-poke behavior in the task. The increase in hold times in the hM4Di^+^ group may indicate uncertainty regarding whether a trial was InSeq or OutSeq and thus a decisional shift rather than a deficit related to basic nose-poke and hold behavior. To further evaluate this possibility, we examined nose-poke distributions for both InSeq and OutSeq trials ([Figures 3I](#F3){ref-type="fig"} and [3J](#F3){ref-type="fig"}). The InSeq distribution shows the proportion of nose pokes in the hM4Di^+^ group remained similar between the Veh and CNO conditions, with only modest differences. On OutSeq trials, however, there was a clear shift in the proportion of trials near the 1-s decision threshold, suggesting a shift toward making InSeq decisions. Thus, the nose-poke differences indicate a decisional shift in the hM4Di^+^ group following CNO administration. Overall, these results demonstrate suppression of mPFC neurons by systemic CNO administration in the hM4Di^+^ group impaired memory for sequences of events, but the effect diminished with subsequent administrations of CNO.

Synaptic Silencing of mPFC→RE Projections Abolished Sequence Memory {#S9}
-------------------------------------------------------------------

Our primary goal was to examine whether mPFC inputs to RE and PER, structures heavily interconnected with the HC, contribute to sequence memory ([@R27]). We tested top-down mPFC inputs using intracerebral CNO infusions (1 μL at 1 μg/μL per cannula) targeting RE and PER (within subject) on different days. The daily schedule for RE and PER infusions was randomized and counterbalanced ([Figure 1F](#F1){ref-type="fig"}) across rats and repeated conditions to avoid an order effect.

We first examined mPFC→RE projections ([Figure 4A](#F4){ref-type="fig"}). Cannula placement for intracerebral infusions was confirmed with cresyl violet ([Figures 4B](#F4){ref-type="fig"}, [S5B](#SD1){ref-type="supplementary-material"}, [S5E](#SD1){ref-type="supplementary-material"}, and [S5G](#SD1){ref-type="supplementary-material"}). Silencing mPFC terminals in RE in the hM4Di^+^ group significantly impaired sequence memory ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}). The effects of CNO infusion clearly differed from Veh infusion (F~(1,9)~ = 130.850, p = 1.000 × 10^−6^), with no differences across repeated conditions ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}; F~(2,18)~ = 1.012, p = 0.366). The interaction between factors was not significant (F~(2,18)~ = 0.914, p = 0.388). Thus, silencing mPFC→RE synapses powerfully and repeatedly abolished sequence memory. Performance of the mCherry-only group showed no significant difference between CNO and Veh conditions or across repeated conditions ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}; infusion: F~(1,8)~ = 0.492, p = 0.503; repeated conditions: F~(2,16)~ = 0.025, p = 0.967; infusion × repeated conditions: F~(2,16)~ = 1.931, p = 0.184), controlling for non-specific CNO effects in RE. A linear regression was performed to investigate the relationship between SMI (CNO and Veh) and repeated conditions for the hM4Di^+^ group, which was not significant ([Figure 4F](#F4){ref-type="fig"}; CNO: Pearson's r = 0.101, R^2^ = 0.010, p = 0.307; Veh: Pearson's r = 0.259, R^2^ = 0.067, p = 0.096). In the hM4Di^+^ group, sequence 1 and sequence 2 were similar across all repeated conditions ([Figure S4C](#SD1){ref-type="supplementary-material"}; first: Veh, t~(g)~ = 0.989, p = 0.348, CNO, t~(9)~ = −1.665, p = 0.130; second: Veh, t~(9)~ = 0.242, p = 0.814, CNO, t~(9)~ = 0.322, p = 0.754, third: Veh, t~(9)~ = −0.506, p = 0.625, CNO, t~(9)~ = 1.069, p = 0.313), indicating a general sequence memory deficit.

We looked at the non-mnemonic effects of mPFC→RE silencing by examining ISI, IOI, and nose-poke behavior. In both the hM4Di^+^ and mCherry-only groups, the ISI and IOI were not significantly different between Veh and CNO conditions ([Figures 4G](#F4){ref-type="fig"} and [4H](#F4){ref-type="fig"}; hM4Di^+^: ISI, t~(29)~ = 0.502, p = 0.619, IOI, t~(29)~ = 0.394, p = 0.696; mCherry: ISI, t~(26)~ = −1.123, p = 0.272, IOI, t~(26)~ = 1.119, p = 0.273). The holding bias during the task did not differ significantly between the Veh and CNO conditions (holding: t~(29)~ = −0.639, p = 0.528; not holding: t~(29)~ = −0.056, p = 0.956). The nose-poke times were mostly similar between Veh and CNO conditions in both the hM4Di^+^ and mCherry-only groups following RE infusions ([Figure 4I](#F4){ref-type="fig"}; hM4Di^+^: OutSeq~Correct~, t~(29)~ = −0.709, p = 0.484; mCherry-only: InSeq~Correct~, t~(26)~ = −0.020, p = 0.984, OutSeq~Correct~, t~(26)~ = −0.777, p = 0.444), but there was a slight and significant increase in the amount of time rats in the hM4Di^+^ group held the nose-poke response in the CNO condition on InSeq trials (InSeq~Correct~: t~(29)~ = −2.760, p = 0.010). We further analyzed poke distributions in the hM4Di^+^ group for all InSeq and OutSeq trials ([Figures 4J](#F4){ref-type="fig"} and [4K](#F4){ref-type="fig"}). The InSeq distribution showed the proportion of nose-pokes remained similar between the Veh and CNO conditions in the hM4Di^+^ group, with a slight increase in holding ([Figure 4J](#F4){ref-type="fig"}). As shown in [Figure 4K](#F4){ref-type="fig"}, CNO infusion in the hM4Di^+^ group decreased the proportion of OutSeq nose-pokes near the short distribution peak (\~0.35--0.6 s) and increased the proportion near the 1-s decision threshold compared with Veh infusion. The nose-poke differences indicate a decisional shift in the hM4Di^+^ group following CNO infusions. Overall, these results provide strong evidence that silencing mPFC→RE leads to inaccurate decisions, not a basic deficit in poke and hold behavior, reflecting deficits in sequence memory.

Synaptic Silencing of mPFC→PER Projections Abolished Sequence Memory {#S10}
--------------------------------------------------------------------

We next examined mPFC→PER projections ([Figure 5A](#F5){ref-type="fig"}). Cannula placement for intracerebral infusions was confirmed with cresyl violet ([Figures 5B](#F5){ref-type="fig"}, [S5C](#SD1){ref-type="supplementary-material"}, [S5E](#SD1){ref-type="supplementary-material"}, and [S5G](#SD1){ref-type="supplementary-material"}). Silencing mPFC→PER projections significantly and consistently impaired sequence memory across repeated conditions in the hM4Di^+^ group ([Figures 5D](#F5){ref-type="fig"} and [5E](#F5){ref-type="fig"}; infusion: F~(1,8)~ = 62.750, p = 4.700 × 10^−5^; repeated condition: F~(2,16)~ = 1.466, p = 0.263; infusion × repeated condition: F~(2,16)~ = 0.118, p = 0.846). Linear regression analysis showed no significant relationship between repeated conditions and SMI following PER infusions with either CNO or Veh in the hM4Di^+^ group ([Figure 5F](#F5){ref-type="fig"}; CNO: Pearson's r = 0.053, R^2^ = 0.003, p = 0.399; Veh: Pearson's r = 0.167, R^2^ = 0.028, p = 0.202). Furthermore, CNO infusion had no significant effect on sequence memory in the mCherry-only group compared with Veh infusion ([Figures 5D](#F5){ref-type="fig"} and [5E](#F5){ref-type="fig"}; infusion: F~(1,8)~ = 0.690, p = 0.430; repeated condition: F~(2,16)~ = 0.092, p = 0.886; infusion × repeated condition: F~(2,16)~ = 1.056, p = 0.351). Additionally, no significant difference was detected between the two sequences under any condition ([Figure S4D](#SD1){ref-type="supplementary-material"}; first: Veh, t~(g)~ = 0.013, p = 0.990, CNO, t~(8)~ = −0.928, p = 0.380; second: Veh, t~(g)~ = −0.169, p = 0.870, CNO, t~(9)~ = −1.101, p = 0.300; third: Veh, t~(9)~ = 1.003, p = 0.342, CNO, t~(9)~ = 0.630, p = 0.545), thus indicating a general sequence memory deficit.

We evaluated non-mnemonic effects of mPFC→PER silencing by examining the ISI, IOI, and nose-poke behavior. In both the hM4Di^+^ and mCherry-only groups, the ISI and IOI did not differ significantly between PER infusions of Veh and CNO ([Figures 5G](#F5){ref-type="fig"} and [5H](#F5){ref-type="fig"}; hM4Di^+^: ISI, t~(29)~ = 0.634, p = 0.531, IOI, t~(29)~ = 0.456, p = 0.652; mCherry: ISI, t~(26)~ = 0.082, p = 0.935, IOI, t~(26)~ = −0.874, p = 0.390). Furthermore, the holding bias during the task did not differ significantly between Veh and CNO conditions (holding: t~(29)~ = 0.322, p = 0.750; not holding: t~(29)~ = 1.595, p = 0.122). Additionally, nose-poke times in the hM4Di^+^ and mCherry-only groups were similar between PER infusions of Veh and CNO ([Figure 5I](#F5){ref-type="fig"}; hM4Di: InSeq~Correct~: t~(29)~ = 0.621, p = 0.540, hM4Di^+^: OutSeq~Correct~: t~(29)~ = 0.055, p = 0.956, mCherry-only: InSeq~Correct~: t~(26)~ = −0.457, p = 0.652, mCherry-only: OutSeq~Correct~: t~(26)~ = −0.707, p = 0.486). We followed up this analysis by evaluating the nose-poke distributions in the hM4Di^+^ group for all InSeq and OutSeq trials following PER infusions ([Figures 5J](#F5){ref-type="fig"} and [5K](#F5){ref-type="fig"}). The proportion of nose pokes in the InSeq distribution was similar between Veh and CNO infusions in the hM4Di^+^ group ([Figure 5J](#F5){ref-type="fig"}). As shown in [Figure 5K](#F5){ref-type="fig"}, CNO infusion led to a decrease in the proportion of OutSeq nose pokes near the short poke distribution, (\~.20-.4 s) and an increase near the 1-s decision threshold, compared with Veh infusion. Thus, the nose-poke differences indicate a decisional shift in the hM4Di^+^ group following CNO administration. Similar to mPFC→RE, these results illustrate that silencing mPFC→PER leads to inaccurate decisions rather than a basic deficit in nose-poke and hold behavior, reflecting deficits in sequence memory.

Differential Role of mPFC Top-Down Inputs to RE and PER {#S11}
-------------------------------------------------------

The results demonstrate activity in both mPFC→RE and mPFC→PER pathways are essential to sequence memory. We next directly compared the effects of silencing mPFC→RE and mPFC→PER projections. Overall, the effects of mPFC→RE and mPFC→PER pathway silencing did not differ significantly from each other across repeated conditions in the hM4Di^+^ group (region: F~(1,8)~ = 1.487, p = 0.257; repeated condition: F~(2,16)~ = 0.291, p = 0.667; repeated condition × region: F~(2,\ 16)~ = 0.343, p = 0.632). We then examined whether silencing mPFC→RE and mPFC→PER pathways impaired different memory retrieval strategies that support sequence memory. Our approach was based on the conceptual model shown in [Figure 6A](#F6){ref-type="fig"}. This model illustrates the theoretical performance curves that would be obtained when using working memory and temporal context memory retrieval strategies plotted as a function of sequential lag distances on OutSeq items. With a working memory strategy, repeated items would be easier to detect at shorter lags because these items occurred more recently. Conversely, with a temporal context memory strategy, repeated items would be easier to detect at longer lags because these items are further away in the original sequence, thereby reducing interference. Therefore, we examined the performance of the OutSeq probe trials across lags, focusing on repeated items (also called backward lags) to test the contributions of temporal context memory and working memory. For this analysis, we calculated the percent change in performance (CNO-Veh) for each rat on each lag, as SMI could not be calculated because we were only analyzing OutSeq trials.

We first looked at items that were repeated in a sequence to see whether silencing mPFC→RE and mPFC→PER projections differentially affected impairment patterns. mPFC→RE silencing resulted in significant differences from no change in performance (0%) on all backward lags (3-back, t~(14)~ = −2.388, p = 0.016; 2-back, t~(26)~ = −4.252, p = 1.21 × 10^−4^; 1-back, t~(29)~ = −5.274, p = 6.00 × 10^−6^). Additionally, mPFC→PER silencing resulted in a significant difference on the 3-back lag, and showed trends toward significant differences from no change in performance on the 2-back and 1-back lags (3-back, t~(21)~ = −4.579, p = 8.15 × 10^−5^; 2-back, t~(27)~ = −1.609, p = 0.059; 1-back, t~(28)~ = −1.639, p = 0.056). These results indicate repeated items were affected by silencing both mPFC→RE and mPFC→PER pathways. An important question is whether the performance patterns differed across lags when directly comparing the effects of mPFC→RE and mPFC→PER pathway silencing. A repeated-measures ANOVA revealed a significant interaction between mPFC→RE silencing and mPFC→PER silencing (region × backward: F~(2,24)~ = 5.395, p = 0.012), with a large effect size (ŋ~p~^2^ = 0.310; [@R19]), but no significant main effects of region or backward lag distance (regions: F~(1,12)~ = 0.721, p = 0.413; backward: F~(2,24)~ = 0.202, p = 0.732). In the hM4Di^+^ group, CNO infusions in RE had the largest performance-impairing effect on 1-back, then 2-back, and the smallest performance-impairing effect on 3-back lags ([Figure 6B](#F6){ref-type="fig"}). In the hM4DI^+^ group, CNO infusions into the PER led to the opposite pattern, with the largest performance drop on 3-back, then 2-back, and the smallest performance drop on 1-back lags ([Figure 6B](#F6){ref-type="fig"}). These impairment patterns match the expected performance decrements (drop lines in [Figure 6A](#F6){ref-type="fig"}) from a selective loss of working memory following mPFC→RE silencing, and a selective loss in temporal context memory following mPFC→PER silencing.

We then evaluated performance during InSeq trials (lag = 0) against no change in performance (0%) following mPFC→RE and mPFC→PER silencing and found no significant differences (InSeq~RE~: t~(29)~ = −1.189, p = 0.122; InSeq~PER~: t~(28)~ = −1.004, p = 0.162). The finding suggests InSeq trials were not affected by silencing mPFC→RE and mPFC→PER pathways. We found no significant differences comparing mPFC→RE and mPFC→PER on InSeq performance levels using a paired-samples t test (t~(28)~ = ---0.982, p = 0.334).

Finally, we examined whether performance on items that skipped ahead in the sequence (forward lags) were affected by mPFC→RE and mPFC→PER pathway silencing. mPFC→RE pathway silencing tended to have a significant effect on 1-forward (t~(29)~ = ---1.644, p = 0.055) and 2-forward (t~(29)~ = −2.725, p = 0.006) lags. mPFC→PER silencing had a significant effect on the 1-forward lag (t~(28)~ = 1.732, p = 0.047), and no significant effect on the 2-forward lag (t~(27)~ = ---0.524, p = 0.303). Overall, this finding suggests performance levels on items that skipped ahead in the sequence were affected by silencing mPFC→RE and mPFC→PER pathways. Direct comparison of the effects of silencing mPFC→RE and mPFC→PER pathways was performed using repeated-measures ANOVA and revealed no significant interactions in the forward lag direction (region × forward: F~(1,27)~ = −0.012, p = 0.915).

DISCUSSION {#S12}
==========

Summary of Main Findings {#S13}
------------------------

We evaluated the hypothesis that top-down prefrontal projections contribute to sequence memory, and separate projections control the execution of different retrieval mechanisms. We first established that two non-overlapping populations of mPFC neurons project to RE and PER. We then demonstrated suppressing mPFC activity impairs sequence memory, indicating mPFC is critical to sequence memory, consistent with other reports (e.g., [@R39]; [@R21]). This finding alone, however, does not address the role of mPFC as top-down control of sequence memory. Therefore, we directly manipulated mPFC circuitry using an hM4Di synaptic-silencing approach. Suppressing activity in mPFC→RE or mPFC→PER pathway effectively abolished sequence memory. These results unambiguously demonstrate top-down mPFC projections are essential to sequence memory. Next, we performed a behavioral lag analysis to determine the differential roles of mPFC→RE and mPFC→PER pathways. Silencing mPFC→RE pathway disrupted backward lags with a pattern resembling a loss of working memory, whereas silencing mPFC→PER pathway disrupted backward lags with a pattern resembling a loss of temporal context memory. Theoretically, working memory and temporal context memory (i.e., graded retrieval strength based on temporal proximity) differentially contribute to retrieval performance when items are repeated. On shorter lags (e.g., ABC[C]{.ul}, lag = −1), working memory strategies lead to better performance and suppressing mPFC→RE activity impairs performance. At longer lags (e.g., ABC[A]{.ul}, lag = −3), temporal context memory strategies lead to better performance and suppressing mPFC→PER activity impairs performance. This strong pathway-specific interaction effect demonstrates, for the first time, top-down mPFC projections control sequence memory, and suggests RE and PER pathways regulate ongoing retrieval strategies.

Testing mPFC Projections with DREADDs in Sequence Memory {#S14}
--------------------------------------------------------

To investigate the top-down role of mPFC in sequence memory, we suppressed synaptic activity in specific mPFC projections ([@R76]; [@R17]; [@R89]; [@R42]) using Gi-coupled (hM4Di) DREADDs ([@R60]; [@R75]) combined with chronic cannulas targeting RE and PER in rats. hM4Di activation in presynaptic terminals reduces transmission and effectively silences the pathway ([@R81]; [@R58]). Here, we focused on terminal fields in RE ([@R76]; [@R17]; [@R89]; [@R42]; [@R94]) and PER ([@R33]) because both regions support bidirectional communication between the HC and mPFC (e.g., [@R3]; [@R94]; [@R27]). To confirm our manipulations localized to these pathways, we carefully mapped mPFC hM4Di expression areas, visualized mPFC→RE and mPFC→PER projection terminals via the co-expression of mCherry (enhanced with IHC), and mapped the tip locations of the infusion cannulas within RE and PER.

It is important to control for non-specific CNO or infusion effects when using hM4Di to evaluate brain-behavior relationships ([@R79]; [@R34]). Thus, we used a fully crossed 2 (hM4Di and hM4Di-free) × 2 (CNO and Veh) experimental design. Notably, we only observed effects of any of our manipulations when we activated hM4Di with CNO and tested sequence memory.

We also performed several analyses to test the alternative hypothesis that non-memory-related behavioral effects account for impaired performance in the sequence task. We saw no effects (under any condition) on the time it took rats to run between sequences, on odor sampling, on reward retrieval activity, or on the overall frequency of nose pokes in which the rats held the nose-poke response for \>1 s or \<1 s (analyzed by ignoring the sequential status of items; see [Results](#S2){ref-type="sec"}). In fact, detailed analysis of all nose-poke times under hM4Di^+^ and CNO conditions revealed a pattern resembling a shift toward inaccurate OutSeq decisions. This was most clearly revealed in the analysis of poke time histograms and the increase in the overall frequency of holds on OutSeq items, without large changes in the distribution variability or peak times. If the rats had shifted to simple reaction time behaviors, we would have expected an increase in premature and variable responses following mPFC inactivation ([@R67]). Finally, the sequence memory effects were consistent across two different sequences. This is important because it eliminates the possibility rats held a single sequence in working memory and focused on a single strategy throughout the entirety of the session, but instead rats were forced to repeatedly retrieve sequences from long-term memory stores.

An important observation we made following repeated i.p. injections was a loss in the behavioral effect on sequence memory, whereas with direct infusions (which were performed after the i.p. injections) we did not see this loss. [@R88] saw a similar effect observing a weak, but significant, CNO-dependent decrease in freezing levels after multiple injections. There are several possible reasons for the decreased efficacy, including changes in the CNO/clozapine metabolism, receptor desensitization, and/or compensatory plasticity across the brain. The fact that direct infusions never lost efficacy might argue in favor of a systemic metabolic effect. However, experiments that directly measure CNO and clozapine levels in blood and cerebral spinal fluid following repeated i.p. injections would be needed to test this hypothesis.

mPFC Pathways to RE and PER Control Retrieval Strategies in Sequence Memory {#S15}
---------------------------------------------------------------------------

Generally, mPFC is considered to have a major role in controlling memory retrieval strategies ([@R77]; [@R23]; [@R29]; [@R71]; [@R50]; [@R27]). We tested this in two specific projection pathways during memory for sequences of events. Importantly, the sequence task we used is related to episodic-like memory processing and depends on the use of multiple cognitive strategies for optimal performance ([@R5], [@R6]).

If rats were using a working memory strategy, then repeated items would be easiest to detect at short lags because those items occurred more recently. On the other hand, if rats were using a temporal context memory strategy (i.e., graded retrieval probabilities determined by the temporal proximity of items in the sequence), then repeated items would be the easiest to detect with longer lags because of reduced interference. Our use of the term temporal context memory refers to the retrieval gradients that are observed in human studies of list learning (e.g., [@R56]; [@R44]). When cued with an item from the list, people will tend to remember the nearby items (short lags), but they are less likely to recall distal items (longer lags). Because verbal recall cannot be performed in animals, the odor sequence task models list learning in rodents using a nonverbal response to probe memory. Temporal context memory is tested with a lag analysis where we expect nearby items to interfere with OutSeq decisions, but not distal items. In the task, working memory is simultaneously tested on reverse lags because delay-match-to-sample strategies can contribute to performance on these trials for nearby items, but less so on distal items (the opposite pattern expected in temporal context memory). Thus, the sequence task places pressure on the ability of rats to regulate retrieval strategies at different lag distances for optimal performance by emphasizing working memory on shorter lags and temporal context memory on longer lags. Here, suppressing mPFC→RE activity had the largest effect on lags = −1 and the smallest effect on lags = −3. This pattern resembles a reduction in a working memory retrieval strategy, is consistent with several studies demon-strating a role for RE in working memory tasks including spatial working memory ([@R14]; [@R35]; [@R57]; [@R94]; [@R38]; [@R61]; [@R95]) and visual-tactile working memory ([@R37]), and is similar to the role of RE in fear memory retrieval ([@R72]).

In contrast, we found that suppressing mPFC→PER had the largest effect on lags = −3 and the smallest effect on lags = −1. This opposite pattern resembles a reduction in a temporal context memory retrieval strategy. Although temporal context memory is primarily attributed to the HC ([@R44]; [@R46]; [@R74]; [@R56]), PER may also be involved in temporal context memory. For example, PER is essential for trace conditioning ([@R53]; [@R8]) and for unitizing representations of discontinuous events ([@R52]; [@R82]). Alternatively, the present results could reflect a role of PER in disambiguating overlapping object features (e.g., [@R64]), as sequences contain mostly the same elements (e.g., ABCA versus ABCB), but this idea would not account for the deficit gradients observed as a function of lag distance. Furthermore, PFC-PER disconnection lesions impair rule shifting in a conditional object-place association task, consistent with a pathway-specific role in behavioral flexibility ([@R41]). Generally, the current results demonstrate, for the first time, RE and PER have specific roles in memory for sequences of events, rats use multiple retrieval strategies during sequence memory, and these strategies can be differentially controlled by reducing mPFC→RE and mPFC→PER pathway activity.

Interestingly, rats showed a similar level of performance deficits on items that skipped ahead in the sequence (e.g., AB[D]{.ul}) following suppression of both mPFC→RE and mPFC→PER. Theoretically, only temporal context memory or ordinal representational strategies (which were not tested here; see [@R69]; [@R73]) can support accurate performance when predicting upcoming items. Thus, these results indicate both mPFC→RE and mPFC→PER are critical for making predictions of upcoming items. The exact nature of each pathway's contribution to memory, however, should be further explored in experiments focused on items skipping ahead farther in sequences, by manipulating positional strategies, and in tasks focused on elapsed time memory across multiple delay periods (e.g., [@R49]; [@R59]).

Conclusions {#S16}
-----------

We present evidence that top-down mPFC pathways targeting RE and PER differentially control the retrieval strategy used to support sequence memory. Generally, the ability to shift retrieval strategies is important for situation-specific memory access and optimal memory-guided behavior. Importantly, RE and PER pathways endow mPFC with the ability to exert top-down control over episodic memory. Future studies should investigate whether these pathways are vulnerable in disorders that affect the temporal organization of memory, such as schizophrenia and Alzheimer disease.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S19}
--------------------------------------

All experimental procedures using animals were conducted in accordance with the Florida International University Institutional Animal Care and Use Committee (FIU-IACUC). Male Long-Evans rats (n = 34; Charles River Laboratories; weighing 250-350 g upon arrival) were used. Rats were individually housed and maintained on a 12-h inverse light/dark cycle (lights off at 10 AM). Rats had *ad libitum* access to food, but access to water was limited to 2--5 min each day, depending on how much water they received as a reward during behavioral training (6--9 ml). All training and testing sessions were conducted during the dark phase (active period) of the light cycle.

METHOD DETAILS {#S20}
--------------

### Sequence memory task {#S21}

The sequence memory task ([@R5]) involves repeated presentations of odor-sequences and requires a rat to determine whether each item (odor) was presented in-sequence (InSeq; by holding the nose-poke response for 1 s) or out-of-sequence (OutSeq; by withdrawing its nose from the port before 1 s). Rats were trained on two sequences, each comprising four distinct odors (*e.g.,* Seq1: A~1~B~1~C~1~D~1~, Seq2: A~2~B~2~C~2~D~2~). Each sequence was presented at either end of a linear track maze. Odor presentations were initiated by a nose-poke, and each trial was terminated after the rat either held the nose-poke response for \> 1 s (InSeq) or withdrew its nose from the port before 1 s (OutSeq). There was a 1 s interval between trials. Water rewards (one packet of aspartame for every 500 mL of water) were delivered below the odor port after each correct response. Following an incorrect response, a buzzer sound was emitted and the sequence was terminated. Each sequence was presented 50-100 times per session; approximately half the presentations included all items InSeq (ABCD) and half included one item OutSeq (e.g., AB[A]{.ul}D, odor A repeated in the 3^rd^ position). Note OutSeq items could be presented in any sequence position except the first position (i.e., sequences always began with an InSeq item). Sequence memory was probed with OutSeq trials (e.g., AB[A]{.ul}D; one OutSeq trial randomly presented per sequence) and lag distances were analyzed to reveal the temporal order memory performance.

### Task apparatus {#S22}

Rats were tested in a noise-attenuated experimental room. The behavioral apparatus comprised a linear track (length, 183 cm; width, 10 cm; height, 43 cm) with walls angled outward at 15° and nose ports at each end through which repeated deliveries of multiple distinct odors could be presented. Photobeam sensors were used to detect nose port entries. Each nose port was connected to an odor delivery system (Med Associates). Odor deliveries were initiated by a nose-poke entry and terminated either when the rat withdrew before 1 s, or after 1 s had elapsed. Water ports were positioned under each nose port for reward delivery. Timing boards (Plexon) and digital input/output devices (National Instruments) were used to measure all event times and control the hardware. All aspects of the task were automated using custom MATLAB scripts (MathWorks R2016a). A 256-channel Omniplex D with video tracking and Cineplex behavior software (Plexon) were used to interface with the hardware in real time and record behavioral data. Odors were organic odorants contained in glass jars (A1: 1-octanol, CAS: 111-87-5; B1: (−) - limonene, CAS: 5989-54-8; C1: I-menthone, CAS: 14073-97-3; D1: isobutyl alcohol, CAS: 78-83-1; A2: acetophenone, CAS: 98-86-2; B2: (1S) - (−) - beta-pinene, CAS: 18172-67-3; C2: L (−) - carvone, CAS: 6485-40-1; D2: 5-methyl-2-hexanone, CAS: 110-12-3) that were volatilized with nitrogen air (flow rate, 2 L/min) and diluted with ultrapure air (flow rate, 1 L/min). To prevent cross-contamination, separate Teflon tubing lines were used for each odor. These lines converged into a single channel at the bottom of the odor port. In addition, a vacuum located at the top of the odor port provided constant negative pressure to quickly evacuate odor traces with a matched flow rate.

### Sequence memory task training {#S23}

Naive rats were initially trained in a series of incremental stages over 15-20 weeks. Each rat was trained to poke and hold its nose in an odor port to receive a water reward. The minimum required nose-poke duration started at 50ms and was gradually increased (in 15ms steps) until a rat reliably held the nose-poke position for 1.2 s for at least 80% of the time over three sessions (200-300 nose-pokes per session). The rats were then habituated to odor presentations in the port (odor A~1~ and A~2~, then odor sequences A~1~ B~1~ and A~2~B~2~) and each rat was required to maintain its nose-poke response for 1 s to receive a reward. The rats were then trained to identify InSeq and OutSeq items. Rats were initially trained on a two-item sequence: they were presented with "AB" and "AA" sequences in equal proportions. The correct response to the first odor was to hold the nose-poke for 1 s (Odor A was always the first item). For the second odor, rats were required to determine whether the item was InSeq (AB; hold for 1 s to receive reward) or OutSeq (AA; withdraw before 1 s to receive a reward). After reaching criterion on the two-item sequence, the number of items per sequence was increased to three and four in successive stages (criterion: 70% correct across all individual odor presentations over three sessions). After reaching criterion performance on the two four-odor sequences (70% correct on both InSeq and OutSeq items), rats underwent surgery for cannula implantation.

### Cannula system {#S24}

A cannula implant system was created using a high-resolution (56 μm) stereolithography 3D printer (ProJet 1200; 3D Systems), suitable for chronic head stages. A custom-designed 3D-printed cannula assembly was created using CAD software (Autodesk Inventor Pro Edition) and assembled with guide cannulas (27 gauge; outer diameter 0.41 mm; inner diameter 0.31 mm; Component Supply Company, FL) targeting the PER bilaterally (A/P −6.0 mm, M/L ± 6.8 mm, D/V −6.0 mm) and a single site aimed at RE (at a 10° angle to avoid the superior sagittal sinus; A/P −1.8 mm, M/L −1.2 mm, D/V −6.7 mm).

### AAV9 microsyringe infusions and cannula placement {#S25}

Rats were anesthetized with isoflurane (induction 5%; maintenance: 2%--3%) mixed with oxygen (800 ml/min) and placed in a stereotaxic apparatus (David Kopf Instruments, Model 900). A protective ophthalmic ointment (Gentak, 0.3%) was applied to the eyes and the scalp was sterilized with applications of isopropyl alcohol (70% in deionized H~2~O) followed by Betadine. The incision site was locally anesthetized with Marcaine® (7.5 mg/ml, 0.5 ml, s.c.) and the skull was exposed following a fish eye incision. Adjustments were made to ensure bregma and lambda were level (±0.05 μm in the D/V plane). Body temperature (35.9-37.5°C) was monitored and maintained throughout surgery using a rectal thermometer and circulating water heating pad. Ringer's solution with 5% dextrose was administered to maintain hydration (5 ml, s.c.), and glycopyrrolate (0.2 mg/ml, 0.5 mg/kg, s.c.) was administered to prevent respiratory difficulties.

Burr holes were drilled bilaterally over mPFC (infusion site; OmniDrill35, World Precision Instruments). Infusions were performed using a 10 μL microsyringe (NanoFil; World Precision Instruments) and an infusion pump (UltraMicroPump III; World Precision Instruments). hM4Di^+^ rats (n = 13) received 0.5 μL injections of the custom AAV-hM4D~i~^nrxn^ (AAV9.CAG.mCherry-2a-hM4D~i~^nrxn^. WPRE.SV40; UPenn Vector Core) bilaterally into mPFC (A/P 3.24mm, M/L ± 0.7mm, D/V from cortex −2.8mm) at a flow rate of 50 nl/min. mCherry-only rats (n = 9) received 0.5 μL injections of the AAV without hM4Di (AAV9.CB7.CI.mCherry. WPRE.rBG; UPenn Vector Core) bilaterally into mPFC. Pilot experiments were performed to determine the viral gestation time and viral expression. One group of rats (n = 4) was injected with AAV9.hM4Di and then perfused at 1 week, 2 weeks, 4 weeks, or 8 weeks. In another set of rats (n = 2), saline was injected into mPFC in the left hemisphere and AAV9.hM4Di was injected into mPFC in the right hemisphere to determine the mCherry fluorescence from the virus. The AAV9.CB7.CI.mCherry was injected into three rats at dilutions of 1:2, 1:4, or 1:8 to measure the expression rate compared with the hM4Di^+^ group to determine the optimal concentration for use in the control group.

Following injection of the viral vector into mPFC, burr holes overlying the PER bilaterally (A/P −6.0 mm, M/L ± 6.8 mm, D/V −6.0 mm) and RE (at a 10° angle to avoid the superior sagittal sinus; A/P −1.8 mm, M/L −1.2 mm, D/V −6.7 mm) were drilled into the skull. The cannula implant was inserted and secured with skull screws (1/8-inch grade 2 (CP) titanium; Allied Titanium Inc.). The head stage was affixed to the surgical screws with dental cement (methyl, methacrylate, Patterson Dental). Dummy cannulas were inserted into the guide cannulas (extending 0.5 μm beyond the tip of the guide cannula) to protect against debris entering the cannula and prevent scar tissue from developing and blocking the inserted tip of the cannula. A protective cap was affixed atop the cannula implant to protect against impact and debris. Excess skin was sutured (black silk suture 4-0, with reverse cutting needle 19 mm, 1/2 Circle; FEN suture). Neosporin® was applied to the skin surrounding the head stage. At the end of surgery, Flunixin (50 mg/ml, 2.5 mg/kg, s.c.), a nonsteroidal anti-inflammatory analgesic, was administered to the rats. The rats were returned to a clean recovery incubator and monitored until they awoke. One day following surgery, the dummy cannulas were checked, the rats were administered a dose of Flunixin, and Neosporin® was reapplied.

### Suppressing mPFC neurons and projections {#S26}

According to the protocol published by [@R75], clozapine-n-oxide (CNO; Cayman Chemical Company) was dissolved in 0.5% DMSO in 0.9% saline (1.0 mg/ml). The CNO dose was selected on the basis of its behavioral effectiveness and ability to inactivate terminal activity when intracerebrally infused over hM4Di-expressing terminals ([@R79]). The vehicle (Veh) was a solution of 0.5% DMSO in 0.9% saline. For i.p. injections, either CNO or Veh was administered. Behavioral testing was initiated at 30 min post-injection (randomized). For intracerebral infusions, needles were made so the infusion tip extended 1 mm past the implanted cannula. CNO and Veh were administered over 10min (at a volume of 1 μL) in both RE and PER. The infusion cannula (32 gauge; outer diameter 0.0095 mm; inner diameter 0.005 mm; Component Supply Company) was left in place for an additional 5min to allow for drug diffusion. Behavioral testing was initiated 30min post-infusion. Both Veh and CNO infusions in RE and PER were counterbalanced and randomized.

### Dual retrograde tracing {#S27}

Alexa Fluor 488 Cholera Toxin Subunit B (CTB-488) and Alexa Fluor 594 Cholera Toxin Subunit B (CTB-594; Molecular Probes; Invitrogen Inc) were dissolved in neutral phosphate buffer (0.06M PB) at 1% (500 mg dissolved in 50 mL of 0.06M PB) concentration. The solution was aliquoted and stored in a −80°C freezer.

Glass pipettes (3.5" 3-000-203 G/X; Drummond Scientific) were pulled using a P2000 Laser-Based MicroPipette Puller (Sutter Instruments) with a tip diameter between 80 -- 100 microns. The tip was examined under the confocal microscope (Olympus FV1200) to verify diameter size and check for any internal flaws. Prior to surgery, the tracer was loaded into a glass pipette which was previously backfilled with mineral oil using a Hamilton syringe (Hamilton Company).

Rats were anesthetized and prepped for surgery as described previously (n = 4). The skull was exposed with a straight incision. Adjustments were made to ensure the bregma and lambda were level (±0.05 μm in the D/V plane). Burr holes overlying RE (at a 10° angle to avoid the superior sagittal sinus; A/P −1.8 mm, M/L −1.2mm, D/V −6.85 mm) and PER (A/P −6.0 mm, M/L −7.2 mm, D/V −6.6 mm) were drilled into the skull (OmniDrill35, World Precision Instruments). Infusions were performed using a glass pipette and an infusion pump (Nanoject III, Drummond Scientific). 0.3μl was injected into RE and 0.5 μl was injected into PER at a flow rate of 1 nl/s. Three of the rats received CTB-488 in RE and CTB-594 in PER and one rat received the opposite. After the tracer was fully injected, 15mins was allotted to allow for diffusion. Negative pressure was added in order to avoid the spread of the tracer along the injection track. The incision site was sutured (black silk suture 4-0, with reverse cutting needle 19 mm, 1/2 Circle; FEN suture) and dressed with Neosporin®. At the end of surgery, Flunixin (50 mg/ml, 2.5 mg/kg, s.c.), a nonsteroidal anti-inflammatory analgesic, was administered to the rats. The rats were returned to a clean recovery incubator and monitored until they awoke. One day following surgery the rats were administered a dose of Flunixin and Neosporin® was reapplied. After a 2-week incubation period, the rats were perfused.

### Histology {#S28}

Rats were anesthetized with isoflurane (5%) mixed with oxygen (800 ml/min), and transcardially perfused with 100 mL phosphate-buffered saline, followed by 200 mL of 4% paraformaldehyde (PFA, pH 7.4; MilliporeSigma). Brains were post-fixed overnight in 4% PFA and then placed in a 30% sucrose solution for cryoprotection. Frozen brains were cut on a sliding microtome (40 μm; coronal plane) into three sets of immediately adjacent sections.

To visualize AAV9.hM4Di expression as well as cannula tracts, half the slices in the first set (set 1) were mounted and coverslipped using Vectashield® antifade mounting medium with 4′,6-diamidino-2-phenylindole. An mCherry reporter molecule was expressed with hM4Di and visualized with a confocal microscope (Olympus FV1200) using standard filter cubes. The remaining slices in set 1 were mounted for a cell body-specific cresyl violet stain and coverslipped with Permount to visualize the cannula placement. A separate set of slices was processed for immunohistochemistry to visualize the extent of infected mPFC terminals in each of the cannula target sites (RE and PER). Free-floating sections were placed in primary antibody solution: polyclonal rabbit anti red fluorescent protein (Rockland Inc.) in 0.1% bovine serum albumin (BVA) at a 1:1000 concentration for 24-48h. The sections were then washed with 0.1 M phosphate buffer (PB), placed in a 1:500 dilution of the secondary antibody (biotinylated goat anti-rabbit, Vector Laboratories) for 2h. After washing, the sections were incubated for 1h using the avidin biotin complex (ABC) Elite kit (Vector Labs) in the diluent at a 1:300 concentration. Following the final washes, brown cell bodies and fibers expressing mCherry were visualized by incubating the tissue in 0.022% 3,3′-diaminobenzidine and 0.003% hydrogen peroxide for approximately 2-4min. Sections were then mounted on chromalum gelled slides, dehydrated in graded methanols, and placed in xylene before being coverslipped with Permount.

To map the spread of the injection, coronal micrographs of whole slices across the frontal cortex of tissue processed for the mCherry antisera were obtained at 100x using a NikonFI-3 mounted on a Nikon Eclipse E600 microscope for each rat ([Figure S6](#SD1){ref-type="supplementary-material"}). The micrographs were transposed over rendered plates drawn from Nissl sections and modified schematic plates ([@R70]) in Procreate (Savage Software Group). These images were imported into Adobe Illustrator (Adobe Inc.) where labeled cell bodies were identified and used to pixelate and create a shaded image of the injection spread, such that the shading intensity (pixilation) corresponded to the density of cell expression. The opacity of the shading was reduced to 40% and images of all rats were superimposed onto one another to create a final schematic at five anterior posterior levels across mPFC.

A series of tissue was processed in a subset of animals (n = 3) for dual immunofluorescence using antibodies for mCherry and NeuN to quantify the DREADD transduction rate in hM4Di^+^ rats. For this, free-floating sections were incubated in the primary antibody rabbit anti-red fluorescent protein for 24-48h. Following PB washes, the tissue was placed in an antisera for NeuN, (Mouse Anti-NeuN Antibody, clone A60; EMD Millipore) for 4h. Following another set of PB washes, the tissue was incubated in fluorophore-conjugated secondary antibodies (VectaFluor Duet Immunofluorescence Double Labeling Kit, DyLight 594 Anti-Rabbit/DyLight 488 Anti-Mouse) for an additional 2h before being mounted onto chrom-alum gelled slides, rinsed in deionized H~2~O, and coverslipped using VECTASHIELD HardSet Antifade Mounting Medium.

For the rats (n = 4) with the dual retrograde tracer, the first set were mounted and coverslipped using Vectashield® antifade mounting medium with 4′,6-diamidino-2-phenylindole. The injection sites and mPFC were visualized with a confocal microscope (Olympus FV1200) using standard filter cubes. To identify mPFC projection cell type, the second set of tissue was processed for immunofluorescence using the antibody for glutamic acid decarboxylase (GAD). Sections were blocked in 0.5% BSA for one hour then placed in the primary antibody, mouse anti-GAD67 (EMD Millipore Inc) at a concentration of 1:2000 for 36h. Following PB washes, the tissue was incubated in the secondary antibody, Dylight 405 goat anti-mouse (Invitrogen Inc) for 3h. Following final washing of tissue, sections were mounted and coverslipped with VECTASHIELD ® Antifade Mounting (Vector Labs).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S29}
---------------------------------------

All data were analyzed in MATLAB 2016a (Mathworks), SPSS 20.0.0, Excel 2016, and FIJI ImageJ using custom scripts and functions.

### Quantification of mPFC cells and fiber density in RE and PER {#S30}

For the dual immunofluorescence using antibodies for mCherry and NeuN identical epifluorescent images of the frontal cortex were captured at 100x with a NikonFI-3 camera using NIS Elements software (Nikon) with filters for red fluorescent protein (hM4Di/ mCherry-labeled neurons) and green fluorescent protein (NeuN-labeled neurons) at three separate anterior posterior levels: at the core of the injection (\~3.2 from Bregma), one level anterior, and one level posterior (± 120 μm in distance). Images were then imported into FIJI ImageJ (Version 2.0.0; NIH), and a uniform region of interest at each level of the prelimbic cortex and anterior cingulate cortex, restricted to layers 5/6, which expressed the greatest density of hM4Di neurons, was selected to estimate the maximum percentage of cells infected. Manual cell counts were conducted using the Cell Counter plug-in in FIJI and the ratio of mCherry labeled neurons to neurons expressing NeuN was calculated and averaged across rats.

The pattern of hM4Di expression in terminals was analyzed using DAB immunohistochemistry in a subset of rats (n = 3) by capturing serial sections across the anterior posterior (AP) plane of RE and PER using at 100x magnification. Photomicrographs were then converted to 8-bit images in FIJI. The mean density was calculated by determining the absolute value of the difference of the mean gray value from the maximum gray area (255) through a ROI for each terminal site (RE or PER). The mean density was then normalized by dividing it over the mean gray density of a reference area consistent across each structure (3V; rhinal fissure) to obtain the relative density (RD) of each ROI. Normalizing the data removed any variability in the intensity of staining across sections and cases. For RE, 100um^2^ ROIs were measured at 6 AP levels for the medial (REm), dorsal (Red) and lateral (REl) division of anterior RE, the medial (REcm), dorsal (REcd) divisions of caudal RE, and perireuniens (periRE). For PER, 50um^2^ ROIs were measured at 3 AP levels for each layer of cortex. The RD was then used to conduct a quantitative analysis of the distribution and density of hM4Di^+^ fibers from mPFC to RE and PER.

The number of dual labeled cells (CTB-594, CTB-488) were counted using the methods mentioned above. Images were taken at 20X magnification using a confocal microscope (FV1200) to look for double-labeling across mPFC layers. Cells were counted in FIJI ImageJ (Version 2.0; NIH) for CTB-488 and CTB-594 labeled cells at eight locations (anterior cingulate cortex, dorsal prelimbic cortex, ventral prelimbic cortex, and infralimbic cortex; at \~3.72 from Bregma and \~3.00 from Bregma). Individual sections were then separated by layers (I, II/III, V, VI) and a uniform ROI (300 μm^2^) was taken at each layer of mPFC to look for double-labeling. Two separate manual cells counts were conducted using the Cell Counter plug-in in FIJI and the ratio of CTB-488 or CTB-594 labeled cells to the total number of DAPI (blue) labeled cells were counted and averaged across animals. For consistency, we processed the colors of the images so mPFC→RE was always green and mPFC→PER was always cyan.

For the GAD stained sets, we looked for double-labeling of GAD67 (blue) and CTB-488/594 labeled cells in mPFC. Images were taken at 60X magnification and analyzed in FIJI for any dual-labeled cells.

### Statistics {#S31}

Performance on the task was analyzed using a number of measures. The first position of each sequence was excluded from all analyses as these items are always InSeq. Expected versus observed frequencies were analyzed with G-tests to determine whether the observed frequency of InSeq and OutSeq responses for a given session significantly differed from the frequency expected by chance. G-tests provide a measure of performance that controls for response bias and is a robust alternative to the *χ*^2^ test, especially for datasets that include cells with smaller frequencies ([@R80]). To compare performance across sessions or animals, a sequence memory index was calculated (SMI; [@R5]) according to the following equation: $$\text{SMI} = \frac{(0.9 \ast {IN}_{\text{cor}})(0.1 \ast \text{OUT}_{\text{cor}}) - (0.9 \ast {IN}_{\text{inc}})(0.1 \ast \text{OUT}_{\text{inc}})}{\sqrt{(0.9 \ast {IN}_{\text{cor}} + 0.9 \ast {IN}_{\text{inc}})(0.1 \ast \text{OUT}_{\text{cor}} + 0.1 \ast \text{OUT}_{\text{inc}}) \times (0.9 \ast {IN}_{\text{cor}} + 0.1 \ast \text{OUT}_{\text{inc}})(0.9 \ast {IN}_{\text{inc}} + 0.1 \ast \text{OUT}_{\text{cor}})}}$$

The parameters of the equation are as follows: INcor = InSeq correct, INinc = InSeq incorrect, OUTcor = OutSeq correct, and OUTinc = OutSeq incorrect. The SMI normalizes the proportion of InSeq and OutSeq items presented during a session and reduces sequence memory performance to a single value ranging from −1 to 1. A score of 1 represents perfect sequence memory; i.e., a rat correctly held its nose-poke response to all InSeq items and correctly withdrew its nose on all OutSeq items. A score of 0 indicates chance performance. Negative SMI scores represent performance levels below that expected by chance. A behavioral curve was analyzed for each rat to determine whether it performed above chance levels by measuring the SMI during each session, excluding CNO infusion days. SMI was calculated to determine if the effects of CNO and Veh differed when administered i.p. and by infusion (RE and PER). Using SPSS, an ANOVA was used to analyze the overall effects of Veh versus CNO between repeated conditions of hM4Di^+^ and mCherry-only groups. In addition, a simple linear regression was used to analyze the relationship between repeated conditions and infusions. Nose-poke duration was analyzed using paired t tests to determine whether rats held their responses significantly longer in InSeq~correct~ than in OutSeq~correct~ trials. Paired t tests were performed to determine any differences between the effects of Veh and CNO on inter-odor-interval and inter-sequence-interval. General poke distributions were created through MATLAB using the session data.

Two distinct types of OutSeq probe trials were used to determine sequence memory: backward lags and forward lags. Backward lags occur when an odor is repeated in the sequence (e.g., AB[B]{.ul}D). In this task there were three backward lags (−3-Back, −2-Back, and −1-Back) indicating the number of stimuli between the original position and the repeated position. Forward lags occur when the sequence skips ahead (e.g., A[D]{.ul}CD). In this particular task, there are two forward lags (+1-Fwd, and +2-Fwd), indicating the number of stimuli between the repeated position and the original position. Lag analyses were used to measure performance on specific forward and backward lag trials for OutSeq items. The accuracy was calculated for each rat. Each individual rat's performance in the Veh condition was subtracted from its performance in the CNO condition for each lag and then divided by the difference in the lag and Veh accuracy. This produced a value that indicated the percent drop in lag performance based on each individual rat's performance in the Veh condition. A paired t test was performed between RE InSeq and PER InSeq performance levels. A one-tailed, one-sample t test was performed to measure differences against no change for all lag distances. A repeated-measures 2×3 ANOVA with a Greenhouse-Geisser correction was performed on the backward lag trials to analyze any interaction effects between RE and PER infusions. A 2×2 ANOVA with a Greenhouse-Geisser correction was performed for the forward lags between RE and PER infusion. The Greenhouse-Geisser was used because the assumption of sphericity is violated for within-subject analysis in most cases and the Greenhouse-Geisser correction is robust to this violation. Finally, t tests and repeated-measures ANOVA in SPSS were conducted for cell counts and fiber densities.
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![hM4Di Expression and Retrograde Labeling of RE and PER in mPFC\
(A) hM4Di-mCherry (purple) and NeuN (neuron-specific; green) cells in mPFC.\
(B) h4MDi expression rates in the prelimbic cortex (PL) and anterior cingulate cortex (AC).\
(C) Axonal mPFC hM4Di expression in RE. hM4Di fiber density in RE across six subdivisions.\
(D) Axonal mPFC hM4Di expression in PER across layers.\
(E) RE (green) and PER (cyan; color was altered for consistency purposes) injections sites with CTB conjugated with Alexa Fluor 488 and 594. mPFC projects to RE and PER from separate cell populations.\
(F) Cell density of mPFC→RE (i) and mPFC→PER (ii) across subregions and layers.\
(G) Conceptual model of mPFC neurons with projections to RE and PER. mPFC provides direct excitatory inputs to RE and PER. mPFC→RE and mPFC→PER pathways originate from two distinct cell populations and project from specific cell layers in mPFC. mPFC→RE projects more toward the lateral parts of RE and mPFC→PER projects to layer I of PER.\
All data are represented as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.](nihms-1534954-f0002){#F1}

![Sequence Memory Task\
(A) A linear track was used with odor ports at each end where two separate four-odor sequences (A~1~, B~1~, C~1~, D~1~, or A~2~, B~2~, C~2~, D~2~) were presented.\
(B and C) Rats had to correctly identify the odor as either InSeq (70% of the time; B) or OutSeq (30% of the time; C).\
(D) After reaching steady-state performance, we focused on two experimental blocks: (1) i.p. injection suppressing mPFC neurons and (2) intracerebral infusions targeting mPFC terminals in RE or PER. The boxes represent a sample schedule. Veh days are denoted in black, and No-Inj days are in white.\
(E) We used the sequence memory index (SMI) as a summary measure. The red line represents the mean SMI of both No-Inj and Veh sessions (sliding window of 10 sessions).\
(F) SMI was not significantly different between the No-Inj and Veh sessions.\
All data are represented as mean ± SEM. ns, not significant.](nihms-1534954-f0003){#F2}

![mPFC Cortex Is Needed for Sequence Memory\
(A) AAV9.hM4Di was injected bilaterally into mPFC.\
(B) Representation of AAV9.hM4Di viral spread in mPFC for all rats (n = 13).\
(C) Performance differed between hM4Di^+^ animals injected with Veh and CNO in the first repeated condition, but not the second and third repeated conditions. No differences between Veh and CNO were detected in the mCherry-only group.\
(D) Individual rat performance for each repeated condition in both groups.\
(E) In the hM4Di^+^ group, there was a positive linear relationship across repeated conditions after CNO injections, but not after Veh injections.\
(F) ISI was not significantly different between the Veh and CNO conditions in either group.\
(G) IOI was not significantly different between the Veh and CNO conditions in either group.\
(H) In the hM4Di^+^ group, nose-poke time was significantly different between the Veh and CNO conditions for both InSeq~correct~ and OutSeq~correct~ trials. No differences between Veh and CNO were detected in the mCherry-only group.\
(I) hM4Di^+^ group poke times show only subtle shifts in behavior.\
(J) hM4Di^+^ group poke times show a decisional shift between the Veh and CNO conditions with more OutSeq trials incorrectly identified as InSeq.\
All data are represented as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant.](nihms-1534954-f0004){#F3}

![Synaptic Silencing of mPFC→RE Pathway Abolished Sequence Memory\
(A) Guide cannulas targeted RE.\
(B) Locations of RE infusion cannulas in all rats (n = 10).\
(C) Schematic representation of mPFC hM4Di fiber density in RE.\
(D) In the hM4Di^+^ group, SMI was significantly different between Veh and CNO conditions in all three repeated conditions. There were no effects in the mCherry-only group.\
(E) Individual rat performances for each repeated condition in both groups.\
(F) In the hM4Di^+^ group, there was no significant relationship between repeated conditions and infusions.\
(G) ISI was not significantly different between RE Veh and CNO infusions in either group.\
(H) IOI was not significantly different between RE Veh and CNO infusions in either group.\
(I) In the hM4Di^+^ group, InSeq~correct~ nose-poke times were significantly different between Veh and CNO. OutSeq~correct~ nose-poke times, however, did not differ significantly between the Veh and CNO conditions. No differences between Veh and CNO were detected in the mCherry-only group.\
(J) hM4Di^+^ group poke times were relatively similar.\
(K) hM4Di^+^ group nose-poke times show a decisional shift (indicated by a star) between the Veh and CNO conditions toward more OutSeq odors incorrectly identified as InSeq.\
All data are represented as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant.](nihms-1534954-f0005){#F4}

![Synaptic Silencing of mPFC→PER Pathway Abolished Sequence Memory\
(A) Guide cannulas into the PER.\
(B) Locations of PER infusion cannulas in all rats (n = 10).\
(C) Schematic representation of mPFC hM4Di fiber density in PER (restricted to region of interest).\
(D) In the hM4Di^+^ group, SMI significantly differed between the Veh and CNO conditions for all three repeated conditions. No differences between Veh and CNO were detected in the mCherry-only group.\
(E) Individual rat performance in each repeated condition for both groups.\
(F) In the hM4Di^+^ group, there was no significant relationship between repeated conditions and infusions.\
(G) ISI was not significantly different between PER Veh and CNO conditions for either group.\
(H) IOI was not significantly different between PER Veh and CNO infusions for either group.\
(I) InSeq~correct~ and OutSeq~correct~ nose-poke times were not significantly different between Veh and CNO conditions in the hM4Di^+^ and mCherry-only groups.\
(J) hM4Di^+^ group nose-poke times show no obvious shifts in nose-poking behavior.\
(K) hM4Di^+^ group nose-poke times show a decisional shift (indicated by a star) where the rats incorrectly identified OutSeq odors as InSeq.\
All data are represented as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant.](nihms-1534954-f0006){#F5}

![The mPFC→RE Pathway Supports a Working Memory Retrieval Strategy, while mPFC→PER Pathway Supports a Temporal Context Memory Retrieval Strategy\
(A) If rats were using a working memory strategy, then repeated items would be easiest at short lags. By contrast, if rats were using a temporal context memory strategy, then repeated items would be the easiest to detect with longer lags.\
(B) mPFC→RE silencing impaired performance most on shorter distances, consistent with a loss of working memory, while mPFC→PER silencing impaired performance most at longer distance, consistent with a loss of temporal context memory.\
All data are represented as mean ± SEM. \*\*p \< 0.01.](nihms-1534954-f0007){#F6}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                    SOURCE                                             IDENTIFIER
  ---------------------------------------------------------------------------------------------------------------------- -------------------------------------------------- ---------------------------
  Antibodies                                                                                                                                                                
  Rabbit anti-Red Fluorescent Protein                                                                                    Rockland, Inc                                      600-401-379
  Mouse Anti-NeuN Antibody, clone A60                                                                                    Millipore Sigma, Inc.                              RRID: AB_2149209; MAB377
  Anti-GAD67 Antibody, clone 1G10.2                                                                                      Milipore Sigma, Inc.                               RRID: AB_2278725; MAB5406
  VectaFluor Duet Immunofluorescence Double Labeling Kit, DyLight 594 Anti-Rabbit (red)/DyLight 488 Anti-Mouse (green)   Vector Laboratories                                DK-8828
  Biotinylated Goat Anti-Rabbit IgG Antibody                                                                             Vector Laboratories                                RRID: AB_2313606; BA-1000
  Goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, DyLight 405                                               Invitrogen                                         35500BID
  VECTASTAIN Elite ABC HRP Kit                                                                                           Vector Laboratories                                PK-6200
  VECTASHIELD Antifade Mounting Medium                                                                                   Vector Laboratories                                H-1200
  VECTASHIELD HardSet Antifade Mounting Medium                                                                           Vector Laboratories                                H-1400
  3,3′-Diaminobenzidine                                                                                                  Sigma-Aldrich                                      CAS: 91-95-2
  Bacterial and Virus Strains                                                                                                                                               
  CAG.mCherry-2a-hM4D~i~^nrxn^                                                                                           AddGene                                            52523
  AAV9.CAG.mCherry-2a-hM4D~i~^nrxn^.WPRE.SV40                                                                            UPenn Vector Core                                  Custom
  AAV9.CB7.CI.mCherry.WPRE.rBG                                                                                           UPenn Vector Core                                  105544-AAV9
  Alexa Fluor 488 Cholera Toxin Subunit B                                                                                Invitrogen                                         C-22841
  Alexa Fluor 594 Cholera Toxin Subunit B                                                                                Invitrogen                                         C-22842
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                             
  1-Octanol                                                                                                              Sigma-Aldrich                                      CAS: 111-87-5
  (−) - Limonene                                                                                                         Sigma-Aldrich                                      CAS: 5989-54-8
  I-Menthone                                                                                                             Sigma-Aldrich                                      CAS: 14073-97-3
  Isobutyl Alcohol                                                                                                       Sigma-Aldrich                                      CAS: 78-83-1
  Acetophenone                                                                                                           Sigma-Aldrich                                      CAS: 98-86-2
  (1S) - (−) - beta-Pinene                                                                                               Sigma-Aldrich                                      CAS: 18172-67-3
  L (−) - Carvone                                                                                                        Sigma-Aldrich                                      CAS: 6485-40-1
  5-Methyl-2-Hexanone                                                                                                    Sigma-Aldrich                                      CAS: 110-12-3
  Clozapine-N-Oxide                                                                                                      Caymen Chemicals                                   ab141704
  Experimental Models: Organisms/Strains                                                                                                                                    
  Rat: Long Evans                                                                                                        Charles River Laboratories                         RRID: RGD_2308852
  Software and Algorithms                                                                                                                                                   
  MATLAB (Version R2016a)                                                                                                <https://www.mathworks.com/products/matlab.html>   RRID: SCR_001622
  OmniPlex (Version 1.17)                                                                                                <https://plexon.com>                               RRID:SCR_014803
  CinePlex (Version 3.6.0)                                                                                                                                                  
  SPSS (Version 20)                                                                                                      <https://www.ibm.com/us-en/?ar=1>                  RRID:SCR_002865
  Excel 2016                                                                                                             Microsoft Office                                   
  Fluoview FV10-ASW Version 04.02.04.05                                                                                  <http://www.olympus-lifescience.com/en/>           RRID:SCR_014215
  FIJI ImageJ 2.0.0v                                                                                                     <https://imagej.nih.gov/ij>                        RRID:SCR_003070

###### Highlights

-   Non-overlapping populations of mPFC cells project to the RE and PER

-   Suppressing mPFC activity impairs sequence memory

-   Silencing mPFC→RE and mPFC→PER leads to distinct deficits in sequence memory

-   mPFC→RE and mPFC→PER pathways control sequence memory retrieval
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